(AU)The Royal Children’s Hospital:The Hugh Williamson Gait Analysis Laboratory is named in recognition of the significant grant that the Hugh Williamson Foundation gave to the Royal Children's Hospital to establish the first gait analysis laboratory in Australia especially for children. The Hugh Williamson Gait Laboratory was first opened on the 19th June 1995 and was funded in its first year through the Hugh Williamson Foundation Grants. Since June 1998, the laboratory has been funded by the Victorian Government.
- Functional Mobility Scale (FMS) Escala de Mobilidade Funcional - The Functional Mobility Scale (2ª versão). Para crianças de 4 a 18 anos com paralisia cerebral.
- D6.1 CGA standard Protocol
- D6.2 A standard protocol of clinical gait analysis is described based on a representative inventory along
La SOFAMEA (Société Francophone d'Analyse du Mouvement chez l'Enfant et l'Adulte) a pour but de promouvoir la recherche dans le domaine de l'analyse de mouvement chez l'enfant et l'adulte sous différents aspects, qu'ils soient cliniques, sportifs ou autres. En ce sens, la SOFAMEA regroupe des professionnels du milieu médical (chirurgiens, médecins MPR,...), paramédical (kinésithérapeutes, podologues,...) et de l'ingénierie. L'échange est ainsi au coeur de cette société pluridisciplinaire.
(IE/UK)Clinical Movement Analysis Society of UK and Ireland:
CMAS was formed to encourage professional interaction, develop and monitor professional standards and training and to stimulate and advance scientific knowledge in the fields of clinical motion analysis.
- CMAS Standards - April 2004 This document details the standards developed by the Standards Working Group of CMAS.
(IT)SIAMOC - Società Italiana di Analisi del Movimento in Clinica:The Italian Society of Clinical Movement Analysis was funded in Pisa (Italy) on June the 11th 1999. The mission of the Society is to foster the study and the clinical application of movement analysis methods, in order to improve the functional evaluation of motor disorders, to enhance the efficacy of the treatments through a quantitative analysis of data and a more focussed treatment planning, to quantify the results of current therapies.
- SIAMOC position paper on gait analysis in clinical practice - 2017 General requirements, methods and appropriateness. Results of an Italian consensus conference. Abstract Gait analysis is recognized as a useful assessment tool in the field of human movement research. However, doubts remain on its real effectiveness as a clinical tool, i.e. on its capability to change the diagnostic-therapeutic practice. In particular, the conditions in which evidence of a favorable cost-benefit ratio is found and the methodology for properly conducting and interpreting the exam are not identified clearly. To provide guidelines for the use of Gait Analysis in the context of rehabilitation medicine, SIAMOC (the Italian Society of Clinical Movement Analysis) promoted a National Consensus Conference which was held in Bologna on September 14th, 2013. The resulting recommendations were the result of a three-stage process entailing i) the preparation of working documents on specific open issues, ii) the holding of the consensus meeting, and iii) the drafting of consensus statements by an external Jury. The statements were formulated based on scientific evidence or experts’ opinion, when the quality/quantity of the relevant literature was deemed insufficient. The aim of this work is to disseminate the consensus statements. These are divided into 13 questions grouped
(USA)Commission for Motion Laboratory Accreditation, Inc.:
CMLA is a nonprofit organization established and operated to enhance the clinical care of persons with disorders of human motion by evaluating and accrediting clinical motion laboratories by a set of standard criteria.
Standard Assessment of Motion System Accuracy:
The GCMAS Standards Committee has proposed a protocol for quantifying the accuracy of a motion analysis system (i.e., how accurate the system is at locating markers). This protocol is intended to test video-based systems that employ reflective markers, though it is possible that it could be used to test systems with active markers as well. SAMSA uses a simple device based on a earlier design used by Jim Richards to compare motion systems.
- Device Plans
- Paper "A proposed standard for assessing the marker-location accuracy of video-based motion analysis systems"
- Action Technology - Motorredutores
Electromyography System: FDA 510(k)
Regulation Number: 890.1375
U.S. Food and Drug Administration
Subpart B--Physical Medicine Diagnostic Devices
Sec. 890.1375 Diagnostic electromyograph.
(a)Identification. A diagnostic electromyograph is a device intended for medical purposes, such as to monitor and display the bioelectric signals produced by muscles, to stimulate peripheral nerves, and to monitor and display the electrical activity produced by nerves, for the diagnosis and prognosis of neuromuscular disease.
(b)Classification. Class II (performance standards).
Regulation Number: 882.5050
Subpart F--Neurological Therapeutic Devices
Sec. 882.5050 Biofeedback device.
(a)Identification. A biofeedback device is an instrument that provides a visual or auditory signal corresponding to the status of one or more of a patient's physiological parameters (e.g., brain alpha wave activity, muscle activity, skin temperature, etc.) so that the patient can control voluntarily these physiological parameters.
(b)Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter when it is a prescription battery powered device that is indicated for relaxation training and muscle reeducation and prescription use, subject to 882.9.
BrasilModelo de Banco de Dados para Exames de Marcha:
- Exemplo (1) Cadastro do Paciente, (2) Histórico, (3) Biomecânica, (4) Exame Físico